Zoledronic Acid 5 MG in 5 ML Injection

DRUG2 trials

Sponsors

Oslo University Hospital, Sahlgrenska University Hospital

Conditions

Neovascular Age-related Macular DegenerationOsteoporosis in Post-menopausal Women

Phase 2

Zoledronic Acid as Adjuvant Therapy in Neovascular Age-related Macular Degeneration (Z-AMD)

CompletedNCT04304755

Oslo University HospitalNeovascular Age-related Macular Degeneration

Start: 2021-10-25End: 2024-01-24Updated: 2024-04-05

Phase 4

Sequential Treatment With Romosozumab Followed by Denosumab vs. Zoledronic Acid for Gains in HIP BMD

Not yet recruitingNCT07772609

Sahlgrenska University HospitalOsteoporosis in Post-menopausal Women

Start: 2027-01-11End: 2031-12-31Target: 216Updated: 2026-08-19